BPC-157 — Experimental Peptide

Overview

BPC-157 is a 15-amino-acid sequence derived from a larger gastric protective protein. In preclinical studies it accelerates healing of tendon, ligament, muscle, bone, gut, and nerve tissue.

Source

Synthesized in research laboratories
Not present in food

Forms

Subcutaneous injection
Oral capsule (research)
Nasal spray (compounded)

Mechanism of action

Believed to upregulate growth-factor receptors, modulate nitric oxide signaling, and promote angiogenesis at sites of tissue damage, accelerating repair across multiple tissue types.

Pathways

· VEGFR2 – Akt – eNOS signaling (angiogenesis)
· FAK – paxillin (cell migration and adhesion)
· Dopaminergic, serotonergic, and GABAergic modulation
· Nitric oxide system stabilization

Receptors

· VEGFR2 (vascular endothelial growth factor receptor)

Enzymes

· Endothelial nitric oxide synthase (eNOS)

How it acts on the body

BPC-157 appears to act less like a classical hormone and more like a 'rescue signal' that the body uses when local tissue is under stress. Once it reaches damaged tissue it amplifies VEGF receptor expression on endothelial cells, which prompts the sprouting of new capillaries. That fresh microvasculature is what supplies oxygen and nutrients to fibroblasts laying down new collagen, so its tissue-repair effect is downstream of an angiogenic effect.

On a systemic level it stabilizes the nitric oxide (NO) system: it can counteract the vasoconstriction caused by NO-synthase inhibitors and rebalance NO tone when it is either too high or too low. It also normalizes dopamine and serotonin signaling in stressed brains, which may explain reports of mood and gut-symptom improvement — the gut and brain share both vagal and serotonergic axes, and BPC-157 modulates both.

Notably, BPC-157 does not appear to elevate growth hormone, IGF-1, or sex steroids — its 'anabolic' reputation is really about local angiogenesis and cell-migration signaling, not endocrine drive.

Hormonal & endocrine impact

How this peptide is reported to shift specific hormones and signaling molecules. Directionality reflects research literature and preclinical models, not clinical prescribing data.

Projected hormonal trajectory

Illustrative curves derived from reported direction of effect. Not measured patient data.

Curves are schematic shapes (sigmoid for increases/decreases, damped oscillation for modulation/stabilization) anchored to a 100% baseline. They communicate direction and tempo of change reported in research literature — not absolute hormone concentrations.

Growth hormone / IGF-1Stabilizes

No direct elevation of GH or IGF-1; some animal data suggest sensitization of growth-factor receptors locally without changing systemic levels.

CortisolModulates

Counter-regulates stress-induced cortisol spikes in animal models, particularly during gastric or neuro-injury stress.

Serotonin (5-HT)Modulates

Restores serotonin synthesis in regions affected by injury or NSAID damage; effect is bidirectional rather than purely stimulating.

DopamineStabilizes

Protects dopaminergic neurons in animal models of haloperidol- and MPTP-induced damage, suggesting buffering of dopaminergic tone rather than a true increase.

Nitric oxideModulates

Restores eNOS signaling — raising NO when suppressed and damping it when excessive, which is part of how it stabilizes blood pressure and gut perfusion.

Effects on the body

Increases

Angiogenesis at injury sites

Supports

Tendon, ligament, and gut lining repair

Decreases

Local inflammatory cytokine load

Optimizes

Gastrointestinal mucosal integrity

Organ system effects

Digestive / Gut

Protects gastric and intestinal lining against NSAID, alcohol, and stress damage in animal models; appears to restore tight-junction integrity and mucosal blood flow.

Skeletal Muscle

Accelerates muscle and tendon healing in rodent crush and transection injuries by recruiting fibroblasts and seeding new microvessels.

Brain & CNS

Modulates dopaminergic and serotonergic activity; shows preliminary neuroprotective signals after traumatic and ischemic injury in animals.

Liver

Hepatoprotective effects against several toxin models, possibly via NO stabilization and reduced oxidative stress.

Cardiovascular

Stabilizes blood pressure during NO inhibition; preliminary data suggest cardioprotection during ischemic challenge.

Reported effects

Drawn from preclinical research, anecdote, and small-scale clinical observation. No evidence grades are assigned — most peptides on this page lack rigorous human trials.

Reported acceleration of soft-tissue recovery (tendon, ligament, muscle)
Anecdotal improvement of gut symptoms in IBD-like presentations
Apparent reduction of joint pain after overuse injuries
Possible neuroprotective and mood-stabilizing effects

Potential side effects

Common

· Injection-site irritation
· Mild head pressure or fatigue
· Transient dizziness

Rare

· Nausea
· Flushing
· Heart-rate fluctuations

Serious

· Unknown long-term human safety profile — no large clinical trials

Drug interactions

NSAIDs

Often discussed as a 'rescue' for NSAID-induced gut damage in animal models.

minor

Anticoagulants

Theoretical bleeding/clotting interaction via angiogenic pathways.

moderate

Pairing context

Often combined with

TB-500
Frequently stacked in research protocols for additive tissue-repair effects.
Collagen peptides
Provides amino-acid substrate for new connective tissue.

Avoid combining with

Active malignancy
Angiogenic activity is theoretically undesirable when tumors are present.

Important. Research peptides described here are not FDA-approved supplements. Supplement Scholar does not endorse, recommend, or link to any source for purchase. Consult a qualified clinician before considering any peptide therapy.